New frontiers in aerosol delivery during mechanical ventilation

Area of Science:

• Pulmonary Medicine
• Pharmacology
• Biotechnology

Background:

• Inhalation therapy is scientifically validated for mechanically-ventilated patients.
• New drug delivery devices enhance lung drug administration efficiency.
• Liposomal encapsulation can improve drug efficacy and reduce side effects.

Purpose of the Study:

• To review advancements in inhalation therapy for mechanically-ventilated patients.
• To explore the potential of novel drug delivery systems.
• To discuss future applications driven by a better understanding of respiratory diseases.

Main Methods:

• Literature review of current research on inhalation devices and drug formulations.
• Analysis of liposomal drug delivery systems for pulmonary administration.
• Synthesis of findings on emerging respiratory disorder mechanisms and therapeutic implications.

Main Results:

• High-efficiency inhalation devices are available for mechanical ventilation.
• Liposomes show promise for enhanced drug delivery, prolonged action, and reduced toxicity.
• Inhaled surfactant has potential in various patient conditions.
• Improved understanding of respiratory diseases opens new avenues for inhaled treatments.

Conclusions:

• Inhalation therapy is a well-established and advancing treatment modality for mechanically-ventilated individuals.
• Novel drug delivery technologies, including liposomes, offer significant improvements.
• Future research into respiratory pathophysiology will drive further innovation in inhaled therapies.